Omada Health, Inc. (OMDA) intrinsic value & 10-year financials
Omada Health, Inc. (OMDA) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 4 fiscal years revenue grew 45.6% a year to $260.2M, with an average return on invested capital of 12.1%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $17.63
- Market cap
- $645.9M
- Revenue (FY2025)
- $260.2M
- Revenue growth (4-yr CAGR)
- 45.6%
- ROIC (10-yr avg)
- 12.1%
- Free cash flow (FY2025)
- $16.9M
OMDA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $260.2M | -$12.8M | -$0.35 | $16.9M | -4.6% | 5.7% |
| FY2024 | $169.8M | -$47.1M | -$6.11 | -$34.8M | -25.7% | 10.1% |
| FY2023 | $122.8M | -$67.5M | -$9.52 | -$50.2M | -53.8% | 20.5% |
| FY2022 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Omada Health, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Omada Health, Inc. returns on capital have been average, hovering around 12.1% ROIC over the decade.
Omada Health, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Omada Health, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-11.63 per share.